Found 18 matching trials
Montelukast - a Treatment Choice for COVID-19 N/A The current study aimed to make a therapeutic comparison and effectiveness ...
Show More Location
Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China
Learn More & Join Trial
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients PHASE2 The (World Health Organization) WHO NOR- (Coronavirus infectious disease) C...
Show More Location
Andreas Barratt-Due
Learn More & Join Trial
Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer PHASE1 The purpose of the study is to compare efficacy of DCVAC/LuCa + chemotherap...
Show More Location
Multiple Locations
Learn More & Join Trial
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy? PHASE4 Global Burden of Diseases ranks chronic kidney disease (CKD) as the 12th le...
Show More Location
Muljibhai Patel Urological Hospital
Learn More & Join Trial
COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU N/A This is a retrospective observational cohort study. About 1000 hospital cha...
Show More Location
City Clinical Hospital No. 52 of the Department of Health of the City of Moscow
Learn More & Join Trial
Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 NA The effective medical treatment against COVID-19 infection is still unknown...
Show More Location
Taoyuan General Hospital, Ministry of Health and Welfare
Learn More & Join Trial
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19 PHASE2 Introduction There are currently no treatments with demonstrated efficacy f...
Show More Learn More & Join Trial
The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients PHASE1 This is a pilot, randomized, single-center, parallel group, open-label cont...
Show More Location
King Hussein Cancer Center
Learn More & Join Trial
Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab N/A This is a single arm, prospective, observational, single center study to as...
Show More Location
University Hospital for Infectious Diseases "Dr Fran Mihaljevic"
Learn More & Join Trial
OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome PHASE3 COVID-19 is a respiratory disease due to a novel coronavirus (SARS-CoV-2) t...
Show More Location
Multiple Locations
Learn More & Join Trial